Free Lambda Freelite chains

The Free Lambda Freelite Chains test quantifies free lambda light chains (FLC λ) in serum to help detect and monitor plasma-cell disorders such as multiple myeloma, AL amyloidosis and monoclonal gammopathy of undetermined significance (MGUS). Offered with convenient at‑home venous blood collection across Dubai and the UAE, this assay provides accurate, laboratory-standard results with rapid turnaround to support diagnosis and treatment monitoring. Results are typically interpreted alongside clinical findings and other tests (SPEP, immunofixation, renal function) to guide management by your physician.

• Free Lambda Light Chains (FLC λ)
• Free Kappa Light Chains (FLC κ)
• Kappa/Lambda Ratio (κ/λ)

• Suspected multiple myeloma or plasma-cell dyscrasia
• Monitoring known myeloma or AL amyloidosis treatment response
• Evaluation of monoclonal gammopathy (MGUS) follow-up
• Unexplained renal impairment with suspected light‑chain nephropathy
• New or recurrent symptoms suggestive of disease relapse

• Sensitive quantitative detection of free light chains
• Home sample collection across Dubai and the UAE
• Fast laboratory turnaround to support timely clinical decisions
• Useful for diagnosis, prognosis and monitoring treatment response
• Results compatible with local physician consultation and follow‑up

• At‑home venous blood (serum) collection by trained phlebotomist
• No fasting typically required—follow specific clinician instructions
• Provide current medication list and recent treatment history (e.g., chemotherapy, immunotherapy)
• Have Emirates ID and valid contact/address details available for the home visit